Whilst AI is amazing, it works well in some circumstances and poorly in others.

Inpharmation has looked carefully at the evidence for AI’s promise in pricing and forecasting (areas where we specialize).

Our latest book, The AI Cube, is a careful evidence-based review of what AI can and cannot do in pricing and forecasting pharmaceuticals.

At Inpharmation, we are making careful and reserved use of AI. But we are not in the business of hyping where evidence is lacking.

If you would like to see a considered review of what AI can do in forecasting and pricing, request a sample chapter of the book here…